DreaMed Advisor Pro vs PeraMobile and PeraWatch
AI Verdict
Choose DreaMed Advisor Pro if…
Choose DreaMed Advisor Pro if your primary goal is to provide highly personalized and AI-driven insulin management for individual patients with Type 1 or Type 2 diabetes. This tool is ideal for optimizing insulin pump settings and offering tailored advice based on comprehensive glucose and insulin data, directly supporting clinicians in fine-tuning treatment plans.
View DreaMed Advisor Pro →Choose PeraMobile and PeraWatch if…
Choose PeraMobile and PeraWatch if your organization requires a system-wide predictive analytics solution to identify at-risk patients across various care settings. This platform is best suited for proactive patient surveillance, enabling earlier intervention for deteriorating conditions, and improving overall quality and safety metrics across an entire hospital or health system.
View PeraMobile and PeraWatch →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | DreaMed Advisor Pro | PeraMobile and PeraWatch |
|---|---|---|
| Pricing | Not publicly disclosed | Contact for pricing |
| Deployment | Cloud-based SaaS | Software-only, integrated with EHRs, web-based access, mobile application, on user-provided hardware. |
| FDA Status | Yes AI-estimated | 1 AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
DreaMed Advisor ProDreaMed Advisor Pro has explicit positive feedback from physicians, with 96% finding it intuitive and user-friendly, and 86% reporting time savings. It also offers a free mobile app and web platform for accessibility. While PeraMobile and PeraWatch offer mobile access and visual dashboards, there is no direct user feedback on its ease of use in the provided information or search results.
Clinical Value
PeraMobile and PeraWatchPeraMobile and PeraWatch, powered by the Rothman Index, have demonstrated significant clinical impact, including a 30% reduction in mortality at major hospitals and improved sepsis outcomes. It also predicts unplanned ICU readmissions and is validated across neonatal, pediatric, and adult populations. DreaMed Advisor Pro shows non-inferiority to expert physicians in diabetes management and improved glycemic control, but PeraHealth's broader impact on overall hospital mortality and patient deterioration across diverse populations gives it an edge.
Pricing & Value
TieNeither DreaMed Advisor Pro nor PeraMobile and PeraWatch publicly disclose their pricing. Both are described as enterprise-level solutions, making it impossible to compare their pricing or assess their value proposition without this crucial information.
Enterprise Readiness
PeraMobile and PeraWatchPeraMobile and PeraWatch explicitly highlight integration with major EHR vendors, including Epic, and offer system-wide virtual surveillance. Its deployment flexibility, including on user-provided hardware, further enhances its readiness for diverse enterprise environments. While DreaMed Advisor Pro is cloud-based and integrates with diabetes management systems, its broader EHR integration capabilities are not as prominently detailed.
Innovation
DreaMed Advisor ProDreaMed Advisor Pro's application of AI for highly personalized, dynamic, and adaptive optimization of insulin pump settings, mimicking expert endocrinologists, represents a sophisticated and complex innovation in diabetes management. Its 'event-driven adaptive learning' refines understanding for individual patient needs. While PeraHealth's Rothman Index is a robust predictive model, DreaMed's specific AI application for personalized therapy demonstrates a slightly higher degree of innovation in its domain.
Support & Docs
TieBoth companies provide evidence of offering support and documentation. DreaMed Advisor Pro mentions a patient user manual and a dedicated support page. Spacelabs Healthcare (PeraHealth's parent company) lists options for opening support tickets and accessing product manuals. Without more specific details on the quality, comprehensiveness, or responsiveness of their support and documentation, it is not possible to definitively pick a winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | DreaMed Advisor Pro | PeraMobile and PeraWatch |
|---|---|---|
| Tool Name | DreaMed Advisor Pro | PeraMobile and PeraWatch |
| Company | DreaMed Diabetes | PeraHealth (acquired by Spacelabs Healthcare) |
| Description | FDA-cleared AI-based clinical decision support software that helps healthcare professionals optimize insulin pump settings and provide personalized diabetes management tips for patients with Type 1 and Type 2 diabetes. | Predictive analytics solutions, powered by the FDA-cleared Rothman Index, to help healthcare providers identify at-risk patients sooner for earlier intervention, improve quality, and reduce costs. |
| Primary Specialties | Endocrinology, Family Medicine, Internal Medicine | Critical Care, Emergency Medicine, Hospital Medicine |
| Key Features (Examples) | AI-based insulin delivery recommendations, Analyzes CGM, SMBG, and insulin pump data, Optimizes insulin pump settings (basal rate, carb ratio, correction factor) | Real-time patient acuity scoring (Rothman Index), Predictive analytics for patient deterioration, Integration with major EHR vendors |
Videos
Demos, reviews, and walkthroughs featuring DreaMed Advisor Pro and PeraMobile and PeraWatch.